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Nowadays, cancer treatment using ionizing radiation 
(IR), also known as radiotherapy, is one of the most 
common modalities. The aim of radiotherapy is to 
eradicate all tumor cells with lowest possible damage to 
the surrounding normal tissues.1 However, radiation 
therapy is associated with some side-effects. Early and 
late side effects of exposure to high doses of 
radiotherapy may limit the radiation doses delivered.2 
Also, a high dose of radiation may affect the long‐term 
quality of life of cancer patients.3 lung inflammation and 
fibrosis is one of the most important late effects of 












Purpose: Lung tissue is one of the most sensitive organs to ionizing radiation (IR). Early and 
late side effects of exposure to IR can limit the radiation doses delivered to tumors that are 
within or adjacent to this organ. Pneumonitis and fibrosis are the main side effects of 
radiotherapy for this organ. IL-4 and IL-13 have a key role in the development of pneumonitis 
and fibrosis. Metformin is a potent anti-fibrosis and redox modulatory agent that has shown 
radioprotective effects. In this study, we aimed to evaluate possible upregulation of these 
cytokines and subsequent cascades such as IL4-R1, IL-13R1, Dual oxidase 1 (DUOX1) and 
DUOX2. In addition, we examined the potential protective effect of metformin in these 
cytokines and genes, as well as histopathological changes in rat’s lung tissues.  
Methods: 20 rats were divided into 4 groups: control; metformin treated; radiation + 
metformin; and radiation. Irradiation was performed with a 60Co source delivering 15 Gray 
(Gy) to the chest area. After 10 weeks, rats were sacrificed and their lung tissues were 
removed for histopathological, real-time PCR and ELISA assays.  
Results: Irradiation of lung was associated with an increase in IL-4 cytokine level, as well 
as the expression of IL-4 receptor-a1 (IL4ra1) and DUOX2 genes. However, there was no 
change in the level of IL-13 and its downstream gene including IL-13 receptor-a2 
(IL13ra2). Moreover, histopathological evaluations showed significant infiltration of 
lymphocytes and macrophages, fibrosis, as well as vascular and alveolar damages. 
Treatment with metformin caused suppression of upregulated genes and IL-4 cytokine 
level, associated with amelioration of pathological changes.  
Conclusion: Results of this study showed remarkable pathological damages, an increase in 
the levels of IL-4, IL4Ra1 and Duox2, while that of IL-13 decreased. Treatment with 
metformin showed ability to attenuate upregulation of IL-4–DUOX2 pathway and other 
pathological damages to the lung after exposure to a high dose of IR.  
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treatment. These side effects are usually associated with 
damage to vascular structures, infiltration of immune 
system cells such as macrophages, lymphocytes and mast 
cells in addition to oxidative damage and tissue 
remodeling.4 Radiation-induced fibrosis develops 
through long term changes in some biological elements 
and processes, such as cytokines and growth factors, 
inflammation, fibroblast differentiation etc.5  
Several experiments have proposed TGF-β, IL-4 and IL-
13 signaling pathways as the most important pathways 
involved in radiation-induced fibrosis.6 TGF-β through 
stimulation of Smad pathway, promotes fibroblast 
differentiation.7 IL-4 stimulates both IL-13 and TGF-β. 
which further amplifies the process of fibrosis. 
Furthermore, IL-4 and IL-13 stimulate production of free 
radicals, a long time after exposure, resulting in chronic 
oxidative stress.8 It has been shown that IL-4 has a two-
fold effect on promotion of fibrosis.9 Upregulation of 
Dual oxidase 1 (DUOX1) and DUOX2 by these 
cytokines play a key role in chronic ROS production, 
inflammation and fibrosis.10 Moreover, it has been 
shown that IL-4 plays a key role in the maintenance of 
macrophages in lung tissues following exposure to 
radiation. On the other hand, macrophages are the main 
source of IL-4 production.11 It has been suggested that 
chronic infiltration of macrophages through production 
of IL-4, plays a central role in the development of 
pneumonitis and lung fibrosis.12 Suppressing these genes 
can ameliorate various side effects induced by IR.  
So far, various agents such as herbal compounds, 
antioxidants etc., have been examined for preventing 
radiation-induced pneumonitis and lung fibrosis.13,14 
Metformin has shown some radioprotective and 
antioxidant effects.15 Moreover, this drug has shown 
ability to ameliorate fibrosis induced by various toxic 
agents such as chemotherapy drugs.16,17 Metformin has 
been shown to possess antioxidant effect via direct 
neutralization of ROS and stimulating antioxidant 
enzymes.18 However, a major effect of metformin is its 
stimulatory effect on DNA repair pathways through 
upregulation of AMP-activated protein kinase (AMPK).19 
AMPK is able to stimulate BER and HR pathways of 
DNA repair, leading to amelioration of clastogenic agents 
such as IR.20,21 Metformin also has a potent inhibitory 
effect on mitochondrial electron transfer chain 1 (ETC1), 
leading to attenuation of superoxide production in 
oxidative stress conditions. In this study, we examined the 
protective effect of metformin (in a non-toxic dose) on 
development of radiation-induced inflammation and 
fibrosis associated with other pathological changes such as 
vascular damage. In addition, we evaluated its effects on 
changes in the levels of pro-fibrotic cytokines such as IL-4 
and IL-13 and their downstream genes, including IL-4Ra1, 
IL-13Ra2, DUOX1 and DUOX2. 
  
Materials and Methods 
Animal preparation  
20 adult male Wistar rats were purchased from Razi 
institute, Tehran University of Medical Sciences, Tehran, 
Iran. Rats weighing 200 ± 20 g were housed in 
accordance to the principles outlined in “The Guide for 
The Care and Use of Laboratory Animals” prepared by 
Kermanshah University of Medical Sciences. All rats 
were kept under controlled conditions, including 
humidity (60 ± 5%), temperature (25 ± 2°C), as well as 
12h light and dark cycle.  
 
Metformin treatment 
Metformin powder was prepared by Tehran Chemie 
Pharmaceutical Company, Tehran, Iran. It was dissolved 
in distilled water at a concentration of 20mg/ml. Oral 
administration of the resulting solution was done 4 and 5 
consecutive days before and after irradiation, 
respectively. On the day of irradiation, metformin was 
administered 30 minutes before irradiation. To obtain a 
non-toxic drug dose as well as optimum radioprotective 
effect, a 100 mg/kg dose of metformin was selected 
based on previous studies.22 
 
Irradiation of animals  
Before irradiation, animals were anesthetized using 
intraperitoneal injection of ketamine 10% at a dose of 80 
mg/kg and xylazine 2% at a dose of 5 mg/kg. The rats 
were irradiated on the thoracic region with a 60Co source 
of gamma rays at a dose rate of 109 cGy/min. A single 
dose of 15 Gy was selected for inducing lung injury 
based on previous study by Ghosh et al.23 
 
Experimental design 
Rats were divided into four groups. Group 1 (control): 5 
rats served as controls without any intervention. Group 2 
(metformin): 5 rats were treated with metformin for 10 
consecutive days. Group 3 (radiation): 5 rats received 15 
Gy gamma rays to their chest area. Group 4 (metformin 
+ radiation): 5 rats were treated with metformin for 4 and 
5 consecutive days before and after irradiation, 
respectively. All animals sacrificed 10 weeks after 
irradiation. Their lung tissues were removed after chest 
surgery. The right lung tissues were frozen immediately 
at -80°C for ELISA and real-time analysis, while the left 
parts were fixed in 10% neutral buffered formalin for 
histopathological assay.  
 
Real-time PCR 
Lung tissues were homogenated and total RNA was 
extracted. The concentration of total RNA was evaluated 
by a nanodrop. The extracted RNAs were transcribed to 
cDNA using cDNA Synthesis Kit (Gene All, South 
Korea). Afterwards, the expression of IL-4R, IL-13R, 
DUOX1 and DUOX2 were quantified using Corbett PCR 
system (USA) and their amplifications were performed 
with master mix green (Ampliqon). Expression of these 
mentioned genes was quantified relative to the reference 
gene and normalized to phosphoglucomutase 1 (PGM1) 
as the housekeeping gene. The genes’ primer sequences 
were designed using Gene Runner software and BLAST 
from NCBI. The primer sequences of IL-4R, IL-13R, 
DUOX1, DUOX2 and PGM1 are shown in Table 1.  
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Table 1. The primer sequences of genes which were used for real-time PCR. 
Gene Forward sequence Reverse sequence 
IL-4R1 GAGTGAGTGGAGTCCCAGCATC GCTGAAGTAACAGGTCAGGC 
IL-13Ra2 TCGTGTTAGCGGATGGGGAT GCCTGGAAGCCTGGATCTCTA 
DUOX1 AAGAAAGGAAGCATCAACACCC ACCAGGGCAGTCAGGAAGAT 
DUOX2 AGTCTCATTCCTCACCCGGA GTAACACACACGATGTGGCG 
PGM1 CATGATTCTGGGCAAGCACG GCCAGTTGGGGTCTCATACAAA 
 
Enzyme-Linked Immunosorbent Assay (ELISA) 
Lung tissues were homogenated by a homogenizer 
device. The levels of IL-4 and IL-13 in the lung 
homogenates were detected by Rat IL-4 and IL-13 
ELISA kits (Zelbio, Germany) according to the 
manufacturer’s instructions.  
 
Histopathological evaluation 
After sacrificing the rats, their left lungs were removed 
and fixed in formalin, and then embedded in paraffin. 
Sections of the removed lungs were cut into 5 µm, 
stained with hematoxylin and eosin (H and E) and 
Masson's trichrome (MTC). All pathological analyses 
were performed at the pathology unit of Imam Khomeini 
Hospital, Tehran, Iran. The blinded pathological study 
was performed with a light microscope using a semi-
quantitative scoring system for the detection of 
histological parameters including fibrosis, edema, 
vascular damage and immune cells infiltration.  
 
Statistical analysis 
The results were presented as mean ± standard deviation 
and P<0.05 was considered statistically significant. Data 
were analyzed using SPSS 16 for Windows, Chicago, 
USA. Results of real-time PCR were analyzed by t-test 
while histopathological and ELISA results were analyzed 
using one-way ANOVA with post-hoc Tukey’s HSD.  
 
Results and Discussion  
Lung is one of the most radiosensitive but late 
responding organ to radiotherapy. During radiotherapy 
for lung cancer or other tumors adjacent to the lung, late 
effects such as pneumonitis and fibrosis may threaten the 
life of patients. Moreover, exposing the lungs to 
radioactive particles after a radiation disaster or during a 
non-uniform whole body irradiation may cause death due 
to pneumonitis or fibrosis, months or years after 
exposure.24 In recent years, several studies have been 
conducted to illustrate the molecular mechanisms of 
radiation injury to the lung. Also, some studies have 
proposed several agents which inhibit inflammatory and 
profibrotic pathways to protect or mitigate lung 
pneumonitis and fibrosis.25-28 Evidences have shown that 
inflammatory and profibrotic cytokines play a key role in 
chronic consequences of exposure to IR in lung tissue.29 
Amongst several cytokines, IL-1, IL-4, IL-6, IL-13, 
TNF-α and TGF-β are the most effective cytokines in 
promoting late effects of radiation injury in various 
organs such as the lung.24,30 IL-4 and IL-13 are able to 
induce continuous oxidative stress which mediate 
chronic inflammation and fibrosis. Studies have shown 
that IL-4, through its receptor IL-4R1, upregulates the 
expression of both DUOX1 and DUOX2, while IL-13 
can upregulate IL13R and DUOX1.31,32 This may 
continue for a long time after exposure to IR, leading to 
disruption of normal function of tissues and increased 
risk of carcinogenesis.30,33 In addition, IL-4 has a key 
role in infiltration of macrophages in the lung and 
subsequent consequences such as promotion of fibrosis 
and inflammation.34 
 
Signs of radiation sickness  
The results of the survival rates of control, metformin 
treated, irradiation and irradiation plus metformin, 
evaluated at the end of the 10th week after local-thorax 
irradiation showed that rats which received metformin 
had healthy signs similar to the control group. In 
addition, those rats which were treated before and after 
irradiation, did not show any sign of radiation sickness. 
However, rats which received gamma rays without 
metformin had signs of reduced weight (possibly because 
of problems in food and water intake), epilation and 
ruffling of their hairs.  
 
Real-time PCR 
In this study, we aimed to evaluate the level of two 
important pro-fibrotic cytokines; IL-4 and IL-13, and 
their downstream genes, including IL4ra1, IL13Ra2, 
DUOX2 and DUOX1 in rat’s lung tissue following 
exposure to a high dose of radiation. We also examined 
the radioprotective effect of metformin on development 
of pneumonitis and fibrosis, infiltration of macrophages 
and lymphocytes, alveolar and vascular damage, as well 
as edema and collagen deposition. As shown in Figure 1, 
the expression of IL4ra1 was significantly increased 
following exposure to IR when compared to control 
group (6.55±0.30, p=0.001). However, in metformin 
treatment group, there was no significant change in the 
expression of this gene. Treatment with metformin could 
attenuate the expression of IL4ra1 significantly, 
compared with IR group (1.91±0.93, p <0.05). Unlike 
IL4ra1, there was no detectable expression of IL-13ra2 
gene in all groups. The expression of DUOX1 increased 
following exposure to IR when compared to control 
group (4.83±1.63, p<0.05). Treatment with metformin 
could attenuate the expression of IL-4r compared to IR 
group (2.15±0.57, p <0.05). Results of DUOX2 gene 
expression showed a significant increase for the radiation 
  700  | Advanced Pharmaceutical Bulletin, 2018, 8(4), 697-704 
Azmoonfar et al. 
group compared with control group (4.23±0.57, p 
≤0.001). Moreover, its expression was significantly 
reduced in rats which were treated with metformin 
(2.09±0.44, p ≤0.001).  
 
 
Figure 1. The expression of IL4Ra1, IL13Ra2 and DUOX2 in 
rat’s lung tissues following irradiation, treatment with metformin, 
and both, (t-test, *p <0.05 is considered a significant difference, 
a: significant compared to control group; b significant compared 
to radiation group). RAD=radiation; MET=metformin. 
 
ELISA 
IL-4 and IL-13 are among important cytokines that 
induce ROS production. As earlier mentioned, IL4Ra1 
and IL13Ra2 are the main receptors of these cytokines. 
As upregulation of these genes are involved in chronic 
oxidative stress and fibrosis, we hypothesized that the 
increased expression of these genes may be associated 
with pathological damages to the lung tissue. In addition, 
we evaluated the levels of IL-4 and IL-13 cytokines as 
well as pathological changes. Afterwards, we examined 
the protective effect of metformin on these changes. As 
shown in Figures 2 and 3, irradiation of lung tissue led to 
an increase in IL-4 level (640±43 pg/ml vs 413±30 
pg/ml). However, treatment with metformin did not 
cause any change in the level of this cytokine. When rats 
were treated with metformin before irradiation, the level 
of IL-4 was suppressed compared to irradiation only 
group (339±36 pg/ml vs 640±43 pg/ml). In contrast to 
IL-4, the level of IL-13 was significantly reduced 
following exposure to IR (243±4 pg/ml vs 215±3 pg/ml), 
(ANOVA, Tukey's HSD, p=0.034). However, no 
changes were observed for treatment with metformin 
before and after irradiation compared with IR group 
(229±14 pg/ml).  
 
 
Figure 2. The levels of IL-4 in rat’s lung tissues following 
irradiation or treatment with metformin, or both. a: significant 
compared to control group; b significant compared to radiation 




Figure 3. The levels of IL-13 in rat’s lung tissues following 
irradiation of rat’s chest area. a: significant compared to control 
group (ANOVA, Tukey's HSD, p<0.05). (ANOVA, Tukey's HSD, 
p<0.05). RAD=radiation; MET=metformin. 
 
Histopathological analyses 
As shown in Table 2, irradiation led to an increase in 
infiltration of macrophages and lymphocytes, thickening 
of alveolar and vascular endothelium as well as edema 
and thrombosis. Treatment with metformin led to 
attenuation of all mentioned factors. In addition, 
irradiation caused a mild fibrosis, which was suppressed 
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by metformin (Figures 4 and 5). It is well known that 
macrophages and lymphocytes are able to release large 
numbers of cytokines that lead to appearance of 
inflammation and fibrosis. Macrophages and 
lymphocytes, through some cytokines induce ROS and 
NO production that have key roles in promotion of 
pneumonitis and collagen deposition.  
 
Table 2. Results of histopathological evaluation of rat’s lung tissues, radiation group was compared to control group while radiation plus 
metformin group was compared to radiation group (a: significant compared to control group, ANOVA, Tukey's HSD, p<0.05).  
 Control Metformin treated Radiation Radiation+Metformin 
Macrophage infiltration 1.00±00 1.00±00 3.66±0.57a 1.5±0.57b 
Lymphocyte infiltration 1.75±0.50 1.00±00 4.00±00a 1.5±0.57b 
Neutrophil infiltration 1.25±50 1.00±00 1.00±00 1.25±50 
Alveolar thickness 1.00±00 1.00±00 2.66±0.57a 1.25±50b 
Vascular thickness 1.00±00 1.00±00 2.00±00a 1.00±00b 




Figure 4. Histopathological effects of irradiation of rat’s lungs and protective effect of metformin. A: Normal; B: Radiation; C: Radiation + 
Metformin. Irradiation caused a mild interstitial infiltration of lymphoplasma, and significant elevation of foam cells. Treatment with 
metformin before and after irradiation caused suppression of all changes in histological parameters (H&E staining).  
 
Metformin is able to modulate cellular metabolism via 
inhibition of reduction/oxidation reactions and 
inflammation. A study by Sato et al. has shown that 
metformin through inhibition of TGF-β–NOX4 signaling 
pathway attenuate Smad phosphorylation and 
myofibroblast differentiation, leading to reduced lung 
fibrosis.16 Modulatory effects of metformin have been 
proposed for protection against radiation injury. It has 
also shown ability to reduce IR-induced cellular damage 
as reported in vitro and in vivo studies.35,36 Metformin 
has shown reduced cell death and micronucleus 
formation in human lymphocytes.35 An in vivo study by 
Xu et al. has shown that metformin suppresses long term 
upregulation of NOX4 in mice bone marrow stem cells 
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following irradiation. This was associated with decreased 
ROS production, DNA damage and apoptosis. Also, 
metformin could stimulate the activity of antioxidant 
enzymes such as superoxide dismutase (SOD) and 
glutathione (GSH).37  
Targeting IL-4 and IL-13 was proposed for mitigation 
of radiation injury in the lung.38 It has been shown that 
suppression of IL-4 can reduce late effects of radiation 
in this organ like fibrosis and macrophage 
accumulation.34 In this study, we showed that the 
expression of IL-4 and its downstream genes involved 
in lung injury after radiation therapy can be potently 
inhibited by metformin.  
 
 
Figure 5. Histopathological effects of irradiation of rat’s lungs and protective effect of metformin. Radiation led to mild fibrosis, while 
metformin reversed it completely. (Massons trichrome staining)  
 
Conclusion 
In this study, we showed that irradiation of rat’s lung led 
to upregulation of IL-4–IL-4R1–DUOX2 pathway, 
associated with inflammation and infiltration of 
macrophages and lymphocytes. However, there was 
significant reduction in the level of IL-13. This could be 
an indication that upregulation of DUOX1 and DUOX2 
by IL-4 is involved in lung injury following exposure to 
IR. Treatment with metformin could suppress 
pathological damages to the lung such as infiltration of 
macrophages and lymphocytes after exposure to a high 
dose of IR. This was associated with a reduction in IL-4 
level as well as expression of IL4Ra1, DUOX1 and 
DUOX2 genes.  
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